At the request of Gov. Ron DeSantis, the Florida Department of Health has opened five additional sites to make sure that COVID-19 patients get the monoclonal antibody treatment they need. The new sites will be located in Broward, Duval, Miami-Dade, Palm Beach, and Seminole counties. “To facilitate the distribution of lifesaving therapeutics the state will…
Florida Opens Five New COVID Treatment Sites as Feds Release Monoclonals
New York Sued for Using Race to Help Determine Who Receives Crucial COVID-19 Treatment
A legal group has filed a lawsuit against the state of New York for refusing to stop using race to help determine which people should receive monoclonal antibodies, a crucial treatment for COVID-19 that has been rationed by the federal government. America First Legal lodged the suit after the New York State Department of Health ignored a…
Feds Allocate Nearly 44,000 COVID-19 Treatments to Florida
The federal government has allocated almost 44,000 monoclonal antibody treatments and anti-viral medications to Florida. The supplies are almost evenly divided between antiviral medications and monoclonals, the Florida Department of Health said in an email. Department press secretary Jeremy Redfern said, “It includes monoclonals and oral treatment options. The bulk of these options being 21,060…
Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
The head of a medical supplies company involved in the distribution and supply of monoclonal antibodies across southeastern and northeastern regions of the nation, told NTD in a Jan. 12 interview that government takeover of the monoclonal antibody supply chain has exacerbated backlogs and shortages. “The way the products are being distributed right now, relying on…
Biden Administration Cuts Florida’s Weekly Monoclonal Shipment in Half
The federal government slashed in half the number of dozes of the monoclonal antibodies therapy shipped to Florida from 30,000 to 15,000 this week, according to Gov. Ron DeSantis (R). DeSantis said the 15,000 dozen received would be “immediately utilized to support new monoclonal antibody sites.” “But for the federal government’s decision to restrict supply…
Supplies Still Limited More Than a Year After Monoclonal Antibodies Authorized for Treating COVID-19
Despite being the only authorized outpatient medical therapy for preventing the worsening of COVID-19 symptoms in high-risk patients, there remains no steady supply of monoclonal antibodies from the federal government a year after its approval for use by medical regulators. Rolled out in the same month as the COVID-19 vaccines, monoclonal antibody therapies have not…
Florida’s DeSantis Says Feds Backed Down on Limiting Monoclonals
Florida Gov. Ron DeSantis announced on Jan. 3 that the federal government had relaxed its policies on limiting monoclonal antibody treatment drugs, paving the way for the state to receive more doses. DeSantis said as soon as more doses were released he would be setting up to 10 new public infusion centers in southern and…
Florida’s DeSantis Says Feds Backing Down on Limiting Monoclonals
Florida Gov. Ron DeSantis announced on Jan. 3 that the federal government had relaxed its policies on limiting monoclonal antibody treatment drugs, paving the way for the state to receive more doses. DeSantis said as soon as more doses were released he would be setting up to 10 new public infusion centers in southern and…
DeSantis: Discovery of Omicron Won’t Provoke Restrictions in Florida
Florida has confirmed cases of the new Omicron variant of the CCP (Chinese Communist Party) virus, Gov. Ron DeSantis announced during a press conference on Dec. 7. The news came as DeSantis was taking questions after unveiling a $270 million spend on 76 projects—across the peninsular state—to help prevent future flooding from “tropical weather” and…
Regeneron Says Antibodies Show Success in Preventing COVID-19 Infections
Monoclonal antibodies that have already proven successful in preventing hospitalizations in people who contract COVID-19 may also serve as protection against COVID-19 infection, according to new data. Regeneron said its monoclonal antibody treatment reduced the risk of contracting the disease by 81.6 percent among uninfected persons. The data comes from a phase three trial run…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`